GB9518572D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9518572D0
GB9518572D0 GBGB9518572.4A GB9518572A GB9518572D0 GB 9518572 D0 GB9518572 D0 GB 9518572D0 GB 9518572 A GB9518572 A GB 9518572A GB 9518572 D0 GB9518572 D0 GB 9518572D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9518572.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9518572.4A priority Critical patent/GB9518572D0/en
Publication of GB9518572D0 publication Critical patent/GB9518572D0/en
Priority to EP96931071A priority patent/EP0859760A1/en
Priority to PCT/EP1996/003990 priority patent/WO1997010210A1/en
Priority to JP51165897A priority patent/JP2001527510A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
GBGB9518572.4A 1995-09-12 1995-09-12 Compounds Pending GB9518572D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9518572.4A GB9518572D0 (en) 1995-09-12 1995-09-12 Compounds
EP96931071A EP0859760A1 (en) 1995-09-12 1996-09-09 Tricyclic pyrrolidine derivatives as calcium channel antagonists
PCT/EP1996/003990 WO1997010210A1 (en) 1995-09-12 1996-09-09 Tricyclic pyrrolidine derivatives as calcium channel antagonists
JP51165897A JP2001527510A (en) 1995-09-12 1996-09-09 Tricyclic pyrrolidine derivatives as calcium channel antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518572.4A GB9518572D0 (en) 1995-09-12 1995-09-12 Compounds

Publications (1)

Publication Number Publication Date
GB9518572D0 true GB9518572D0 (en) 1995-11-15

Family

ID=10780552

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9518572.4A Pending GB9518572D0 (en) 1995-09-12 1995-09-12 Compounds

Country Status (4)

Country Link
EP (1) EP0859760A1 (en)
JP (1) JP2001527510A (en)
GB (1) GB9518572D0 (en)
WO (1) WO1997010210A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1600599A (en) 1998-02-27 1999-09-15 Warner-Lambert Company Heterocyclic substituted aniline calcium channel blockers
US6166052A (en) * 1998-03-11 2000-12-26 Warner-Lambert Company Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
WO2000021550A2 (en) * 1998-10-13 2000-04-20 President And Fellows Of Harvard College Methods and compositions for treating neurodegenerative diseases
AR022229A1 (en) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg TRIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND USE OF THE SAME TO PREPARE SUCH COMPOSITION
WO2003024935A2 (en) 2001-09-19 2003-03-27 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
NZ567540A (en) 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
DK2155663T3 (en) 2007-06-15 2018-01-22 Newron Pharm Spa SUBSTITUTED 2- [2- (PHENYL) ETHYLAMINO] ALKANAMIDE DERIVATIVES AND THEIR USE AS SODIUM AND / OR CALCIUM CHANNEL MODULATORS
HUE030031T2 (en) 2011-06-27 2017-04-28 Newron Pharm Spa Fluorinated arylalkylaminocarboxamide derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
TW334423B (en) * 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
GB9500691D0 (en) * 1995-01-13 1995-03-08 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
WO1997010210A1 (en) 1997-03-20
EP0859760A1 (en) 1998-08-26
JP2001527510A (en) 2001-12-25

Similar Documents

Publication Publication Date Title
GB9508810D0 (en) Compounds
GB9504910D0 (en) Compounds
GB9518572D0 (en) Compounds
GB9512129D0 (en) Compounds
GB9504948D0 (en) Compounds
GB9502540D0 (en) Compounds
GB9507290D0 (en) Compounds
GB9507693D0 (en) Compounds
GB9501580D0 (en) Compounds
GB9501581D0 (en) Compounds
GB9502782D0 (en) Compounds
GB9502784D0 (en) Compounds
GB9502785D0 (en) Compounds
GB9502983D0 (en) Compounds
GB9503211D0 (en) Compounds
GB9504801D0 (en) Compounds
GB9509431D0 (en) Compounds
GB9504803D0 (en) Compounds
GB9504907D0 (en) Compounds
GB9509432D0 (en) Compounds
GB9504990D0 (en) Compounds
GB9506168D0 (en) Compounds
GB9506703D0 (en) Compounds
GB9507040D0 (en) Compounds
GB9504802D0 (en) Compounds